
KromaTiD announces addition of James Chomas to board of directors
LONGMONT -- KromaTiD announced Colorado biomedical entrepreneur James Chomas has joined the company's board of directors. Chomas has a track record of developing innovative healthcare... Read More
Friday February 12, 2021 0 comments

CereHealth welcomes new members to scientific and medical advisory board
DENVER -- CereHealth Corp. today announced the addition of James Chomas and Ty Vachon to the company’s scientific and medical advisory board. Chomas and Vachon join retired Major General... Read More
Thursday December 17, 2020 0 comments

Surefire Medical closes on $12.8M Series D funding
WESTMINSTER -- Surefire Medical, Inc. , developer of site-specific delivery devices for the interventional oncology market, announced the first closing ofa $12.8 million Series D financing round.... Read More
Friday March 10, 2017 0 comments

Surefire Medical reaches critical commercialization milestone in Germany
WESTMINSTER -- Surefire Medical, Inc. today announced the German Institute of Medical Documentation and Information (DIMDI) has issued a unique classification code (OPS) for the Surefire... Read More
Monday September 12, 2016 0 comments

Surefire Medical closes $15M Series C funding for Surefire Precision
WESTMINSTER -- Surefire Medical Inc. , a commercial-stage company developing a new class of direct-to-tumor delivery systems used in minimally invasive interventional procedures, announced the... Read More
Thursday December 3, 2015 0 comments

Surefire Medical launches Precision liver tumor drug delivery infusion system
WESTMINSTER -- Surefire Medical Inc . today announced the launch of its new Precision targeted delivery infusion system for direct-to-tumor embolization procedures. The new technology will be... Read More
Friday September 25, 2015 0 comments

Surefire Medical adds Qool Therapeutics CEO Beverly Huss to directors
WESTMINSTER - Surefire Medical Inc. announced it has appointed Beverly Huss to its board of directors. "Beverly's experience in developing minimally invasive approaches to treating... Read More
Monday November 17, 2014 0 comments